Results 141 to 150 of about 31,995 (218)

Pneumococcal serotype distribution and outcomes in cancer patients with community-acquired pneumonia: A prospective study using the 15-valent pneumococcal conjugate vaccine serotype specific urinary antigen detection assay. [PDF]

Int J Infect Dis
Cintrón M, Gali V, Li Y, Jani K, Cander S, Kaltsas A, Kamboj M, Seo SK, Papanicolaou GA, Lee YJ.   +9 more
europepmc   +1 more source

Cost-effectiveness of a 13-valent pneumococcal conjugate vaccine compared with currently available pneumococcal conjugate vaccines in Indian children. [PDF]

IJID Reg
Taur SR, Rampal R, Sathyanarayanan S, Nahdi FB, Wannaadisai W, Fletcher MA, Huang L.   +6 more
europepmc   +1 more source

The impact of 10-valent pneumococcal conjugate vaccine on the incidence of admissions to hospital with hypoxaemic and non-hypoxaemic pneumonia in Kenyan children. [PDF]

PLOS Glob Public Health
Haeusler IL, Kagucia EW, Bottomley C, Otiende M, Nyiro J, Scott JAG.   +5 more
europepmc   +1 more source

Correction to: Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. [PDF]

Open Forum Infect Dis
europepmc   +1 more source

A Cost-Effectiveness Analysis of the Switch to 20-Valent Pneumococcal Conjugate Vaccine from Lower-Valent Pneumococcal Conjugate Vaccines in the French Pediatric Population. [PDF]

Infect Dis Ther
Fiévez S, Ta A, Bellier L, Blanc E, El Khoury JY, Beillat M, Sabra A, Sivignon M, Ilic A, Perdrizet J.   +9 more
europepmc   +1 more source

Immunogenicity, safety and adverse events of sequential vaccination with a 10-valent pneumococcal conjugate vaccine (PCV10) and PPSV23 compared with PPSV23 alone in systemic lupus erythematosus. [PDF]

Lupus Sci Med
Chatterjee R, Kommaraju SY, Mettingal Ramakrishnan S, Ravikumar KL, Aggarwal A.   +4 more
europepmc   +1 more source

Pneumococcal carriage among children and adults before and after a change from a three-dose 13-valent pneumococcal conjugate vaccine schedule without a booster to a two-dose schedule with a booster in Burkina Faso. [PDF]

Vaccine
Childs L, Zoma RL, Ouedraogo I, Sawadogo G, Tarbangdo TF, Zoma A, Ouangraoua S, Dama E, Tran T, Akhter F, Utreja S, Ouattara M, Verani JR, Sanou S, Aké HF, McGee L, Kobayashi M.   +16 more
europepmc   +1 more source

Sex-based difference in immune responses and efficacy of the pneumococcal conjugate vaccine. [PDF]

J Leukoc Biol
Tchalla EYI, Betadpur A, Khalil AY, Bhalla M, Bou Ghanem EN.   +4 more
europepmc   +1 more source

III. Characteristics and Differences in Pneumococcal Vaccines; 2. Pneumococcal Conjugate Vaccine

Nihon Naika Gakkai Zasshi, 2015
openaire   +3 more sources